The government can help defend Australia's pharmaceuticals sector employees against further job losses by implementing recommendations of the Pharmaceuticals Industry Strategy Group's Final Report, the trade body Medicines Australia's chief executive, Ian Chalmers, has declared.
The report was released on January 30 by the Minister for Innovation, Industry, Science and Research, Senator Kim Carr. It recommends that Australian's government sets up a strategic industry investment fund to support major pharmaceutical manufacturing and R&D activity. and calls for measures to reverse the nation's declining global competitiveness as a destination for clinical trials.
"I urge the government to implement the recommendations of this report without delay. These measures will help defend Australia's pharmaceuticals industry from further job losses and contribute to its long-term viability," Mr Chalmers said. "Government inaction on this issue, especially at this time of economic stress, could have heavy consequences for the industry and for Australian jobs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze